Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients
β Scribed by A. Di Sabatino; R. Ciccocioppo; L. Benazzato; G. C. Sturniolo; G. R. Corazza
- Book ID
- 108603550
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 67 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
MANABU FUKUMOTO, 2 JUN FUJITA, 3 AND MASAYUKI IMAMURA 1 liver tumors, whereas basic FGF may be involved in the Hepatocellular carcinoma (HCC) is a typical hypervasinvasion of HCC into the surrounding tissues. (HEPATOLcular tumor. However, the relationship between the vas-OGY 1996;23:455-464.) culari
Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels